We recently published 10 Stocks Beating Wall Street at its Own Game. Nuvation Bio Inc. (NYSE:NUVB) is one of the best-performing stocks on Wednesday. Nuvation Bio saw its share prices jump to a new three-year high on Wednesday, as investors took path from an investment firm’s bullish coverage for its stock. At intra-day trading, the stock soared to its highest price of $7.35 before paring gains to end the day just up by 48.96 percent at $7.15 apiece. Nuvation Bio (NUVB) Jumps to 3-Year High on Bullish C ...

股价表现 - Nuvation Bio股价在美国东部时间周二上午11点20分飙升157% [1] 积极进展 - 公司宣布其用于治疗切除后ROS1阳性早期非小细胞肺癌的Ibtrozi三期临床研究已完成首例患者入组 [2] - 投资银行Jefferies首次覆盖Nuvation Bio并给予买入评级 同时设定目标价为10美元 较2025年9月29日周一收盘价有约210%的上涨潜力 [2] 市场观点 - Jefferies设定的10美元目标价是华尔街对Nuvation Bio最高的12个月目标价 [4] - 根据S&P Global在9月的调查 所有10位接受调查的分析师均给予Nuvation Bio“买入”或更高评级 [4] - 尽管Ibtrozi于2025年6月获得美国监管批准用于治疗局部晚期或转移性ROS1+非小细胞肺癌 但公司目前产品线单一且尚未盈利 [6]